Fcγ Receptor Heterogeneity in Leukocyte Functional Responses.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28373871)

Published in Front Immunol on March 20, 2017

Authors

Carlos Rosales1

Author Affiliations

1: Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México , Ciudad de México , Mexico.

Articles cited by this

(truncated to the top 100)

Fcgamma receptors as regulators of immune responses. Nat Rev Immunol (2008) 11.34

Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature (2006) 9.30

IgG Fc receptors. Annu Rev Immunol (2001) 8.63

Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science (2006) 8.13

FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol (2007) 7.94

Fc receptors. Annu Rev Immunol (1991) 7.92

Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science (2005) 6.48

Fcgamma receptors: old friends and new family members. Immunity (2006) 5.60

High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem (2000) 5.18

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem (2002) 5.10

Fc receptor biology. Annu Rev Immunol (1997) 5.08

The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol (2007) 4.96

Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol (2007) 4.65

FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity (2005) 4.22

The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem (2002) 4.11

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science (2008) 4.11

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood (2008) 4.10

Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov (2009) 3.66

The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med (2004) 3.56

Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol (2012) 3.39

Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol (2006) 3.04

Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity (2004) 2.79

The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature (1988) 2.66

The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature (1988) 2.65

Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med (2005) 2.53

Properties of mouse and human IgG receptors and their contribution to disease models. Blood (2012) 2.53

Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol (2008) 2.52

A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest (1997) 2.48

NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol (2013) 2.39

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci U S A (2010) 2.36

MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol (2001) 2.33

Structure and function of immunoglobulins. J Allergy Clin Immunol (2010) 2.22

Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med (2013) 2.13

NETosis: how vital is it? Blood (2013) 2.11

Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest (2005) 2.10

Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood (1999) 2.02

Antibodies, Fc receptors and cancer. Curr Opin Immunol (2007) 1.89

Antibody-mediated modulation of immune responses. Immunol Rev (2010) 1.84

A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs. J Clin Immunol (2010) 1.84

Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum (1995) 1.80

The many faces of ITAMs. Trends Immunol (2007) 1.79

Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J Exp Med (1990) 1.79

Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol (2006) 1.77

Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet (1993) 1.72

Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J Exp Med (2000) 1.68

NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood (2013) 1.66

FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy. Tissue Antigens (2003) 1.64

Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther (2009) 1.63

Fc receptors and their interaction with complement in autoimmunity. Immunol Lett (2005) 1.60

Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol (2000) 1.59

IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity (2001) 1.56

Involvement of Fcgamma receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum (2000) 1.56

Signal transduction during Fc receptor-mediated phagocytosis. J Leukoc Biol (2002) 1.52

FcγRs in health and disease. Curr Top Microbiol Immunol (2011) 1.51

Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest (1990) 1.51

Novel roles for the IgG Fc glycan. Ann N Y Acad Sci (2012) 1.51

Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J Immunol (2001) 1.48

Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J Immunol (1982) 1.47

Soluble Fc gamma receptors. J Leukoc Biol (1993) 1.45

Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun (1991) 1.45

FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood (1998) 1.40

Fc gamma receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fc gamma receptor II. J Immunol (1991) 1.38

Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J Immunol (1991) 1.36

FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation. J Clin Invest (2008) 1.35

Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol (1997) 1.32

Ethnic variation in frequency of an allelic polymorphism of human Fc gamma RIIA determined with allele specific oligonucleotide probes. J Immunol Methods (1994) 1.32

Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood (2003) 1.32

Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol (2013) 1.30

FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood (2006) 1.30

Engineered therapeutic antibodies with improved effector functions. Cancer Sci (2009) 1.29

Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16. J Immunol (1994) 1.27

Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest (1990) 1.27

Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res (2013) 1.26

Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis (1994) 1.25

Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma. J Immunol (2000) 1.23

Structural bases of Fc gamma receptor functions. Immunol Rev (1992) 1.23

Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). Blood (1990) 1.22

Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J Clin Invest (1989) 1.22

Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol (1998) 1.18

Endocytosis of soluble immune complexes leads to their clearance by FcγRIIIB but induces neutrophil extracellular traps via FcγRIIA in vivo. Blood (2012) 1.18

Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj J (1997) 1.14

Low-affinity Fcgamma receptors, autoimmunity and infection. Expert Rev Mol Med (2009) 1.14

Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization. Immunology (2007) 1.10

ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activation. J Immunol (2013) 1.07

Fcγ receptors inhibit mouse and human basophil activation. J Immunol (2012) 1.06

Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood (1997) 1.05

TGF-beta 1 suppresses [correction of supresses] myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit. J Immunol (2003) 1.05

ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils. Biochim Biophys Acta (2012) 1.05

The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum (1998) 1.05

Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol (2008) 1.04

Mouse and human FcR effector functions. Immunol Rev (2015) 1.04

Human basophils express the glycosylphosphatidylinositol-anchored low-affinity IgG receptor FcgammaRIIIB (CD16B). J Immunol (2009) 1.03

Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice. J Immunol (1990) 1.01

Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J Immunol (2012) 0.99

Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun (1999) 0.98

Cross-linking of Fc gamma receptor IIa and Fc gamma receptor IIIb induces different proadhesive phenotypes on human neutrophils. J Immunol (1997) 0.98

FcγRIIb on liver sinusoidal endothelium clears small immune complexes. J Immunol (2012) 0.98

Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. J Neurosci Res (2002) 0.97

Negative signaling in Fc receptor complexes. Adv Immunol (2006) 0.97

Membrane anchoring and spontaneous release of CD16 (FcR III) by natural killer cells and granulocytes. Eur J Immunol (1989) 0.96